New Key Statistics Module, Z-Score and F-Score
SZSE:003020 Key Ratios
Market Cap ¥ M | 3,450.21 |
Enterprise Value ¥ M | 3,140.12 |
P/E(ttm) | 18.01 |
PE Ratio without NRI | 17.28 |
Forward PE Ratio | -- |
Price/Book | 2.01 |
Price/Sales | 2.42 |
Price/Free Cash Flow | 486.76 |
Price/Owner Earnings | 103.51 |
Payout Ratio % | 0.40 |
Revenue (TTM) ¥ M | 1,422.00 |
EPS (TTM) ¥ | 1.00 |
Beneish M-Score | -2.42 |
10-y EBITDA Growth Rate % | 14.00 |
5-y EBITDA Growth Rate % | 12.00 |
y-y EBITDA Growth Rate % | -21.70 |
EV-to-EBIT | 14.97 |
EV-to-EBITDA | 14.97 |
PEG | 1.44 |
Shares Outstanding M | 191.57 |
Net Margin (%) | 13.42 |
Operating Margin % | 12.78 |
Pre-tax Margin (%) | 14.65 |
Quick Ratio | 1.75 |
Current Ratio | 2.19 |
ROA % (ttm) | 8.33 |
ROE % (ttm) | 11.76 |
ROIC % (ttm) | 13.50 |
Dividend Yield % | 2.78 |
Altman Z-Score | 5.33 |
SZSE:003020 Number of Guru Trades
SZSE:003020 Volume of Guru Trades
Gurus Latest Trades with SZSE:003020
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:003020 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hefei Lifeon Pharmaceutical Co Ltd Insider Transactions
No Available Data